Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
N-type voltage-gated calcium channels (CaV2.2) and their associated potassium channels, such as the large-conductance calcium-activated potassium (BK) channels, form integrated macromolecular signaling complexes at presynaptic terminals [1, 2]. These complexes are fundamental to the regulation of neurotransmitter release; CaV2.2 mediates the calcium influx necessary for vesicle fusion, while the associated potassium channels provide a rapid repolarization mechanism to limit the duration of the calcium signal [2]. In pathological states like chronic and neuropathic pain, the activity of these complexes is often upregulated, leading to excessive release of excitatory neurotransmitters in the spinal cord's dorsal horn [3]. Drugs like ziconotide specifically target the N-type channel to block this pathway, providing potent analgesia for refractory pain [3, 4]. However, the complexity of these channel interactions and their widespread distribution in the central nervous system present significant challenges, including narrow therapeutic windows and potential for severe neurological side effects [3]. Understanding the precise stoichiometry and functional coupling of these channels remains a key area of research for developing more selective and safer neuro-modulatory therapies.
The primary mechanism involves the selective blockade of the N-type calcium channel (CaV2.2) alpha-1B subunit, which prevents the influx of calcium ions into presynaptic terminals and inhibits the release of pro-nociceptive neurotransmitters such as glutamate, calcitonin gene-related peptide (CGRP), and substance P [1, 3]. Additionally, the functional coupling with associated potassium channels (e.g., BK channels) allows for the modulation of membrane potential, where potassium efflux promotes hyperpolarization and further suppresses neuronal excitability [2].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent N-type calcium channel and associated potassium channels (CaV2.2/K+ complex).